Foscarnet sodium is a decree anesthetic accustomed by the U.S. Food and Drug Administration (FDA) for the analysis of cytomegalovirus (CMV) retinitis (a viral infection and deepening of the eye’s retina) in individuals with AIDS. Foscarnet sodium is aswell FDA-approved for the analysis of a assertive blazon of canker canker virus (HSV) infection, alleged mucocutaneous acyclovir-resistant HSV infection, in humans with attenuated allowed systems.
CMV diseases—such as those affecting the eye (retinitis), esophagus (esophagitis), or colon (colitis)—and HSV diseases are adept infections. An adept infection is an infection that occurs added frequently or is added astringent in humans with attenuated allowed systems—such as those adulterated with HIV—than in humans with advantageous allowed systems.
Foscarnet sodium can aswell be used “off-label” to anticipate and amusement added adept infections of HIV infection. “Off-label” use refers to use of an FDA-approved anesthetic in a address altered from that declared on the anesthetic label. Good medical convenance and the best interests of a accommodating sometimes crave that a anesthetic be used “off-label.”